Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-040454

Chief Financial Officer sold 8,000 shares at $25.00 ($200,000)

  • Chief Financial Officer acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Trigilio Jeffrey · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-15 Exercise or conversion : show line 1 in the form +8,000 $4.30 $34,400 10,250 D
2021-10-15 Sale : show line 2 in the form −8,000 $25.00 $200,000 2,250 D
Open-market sales · 8,000 sh · avg $25.00 · $200,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-15 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −8,000 229,891 D
Loading xslF345X03/doc4.xml…